Caxton Associates (New York)’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18,093
| Closed | -$98.2K | – | 657 |
|
|
2022
Q4 | $98.2K | Buy |
+18,093
| New | +$98.2K | 0.01% | 399 |
|
|
2022
Q3 | – | Sell |
-21,388
| Closed | -$106K | – | 695 |
|
|
2022
Q2 | $106K | Buy |
+21,388
| New | +$106K | 0.01% | 494 |
|
|
2020
Q2 | – | Sell |
-13,388
| Closed | -$148K | – | 649 |
|
|
2020
Q1 | $148K | Buy |
+13,388
| New | +$148K | 0.03% | 366 |
|